The global Carina Endobronchial Blocker market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Carina Endobronchial Blocker competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

The carina-type endobronchial blocker is an advanced medical device, mainly used in thoracic surgery and surgery requiring single-lung ventilation. Its core feature is its unique carina-type design, which can be accurately placed in the carina of the bronchus, and block the ventilation of the target lobe by inflation, while maintaining normal ventilation of the other lobe. This design allows more precise control of lung ventilation during surgery, improving the safety and success rate of surgery. The carina-type endobronchial blocker is usually composed of multiple components such as a catheter, a balloon, an inflation connector, and a conversion connector. Among them, the catheter is used to guide the blocker into the bronchus, and the balloon is inflated to block the airway. The inflation connector is used to connect the inflation device, and the conversion connector is used to connect the ventilator or other medical equipment to achieve airway switching and ventilation control.

With the continuous advancement of medical technology and the increase in clinical application demand, the carina-type endobronchial blocker market has shown a steady growth trend. Especially in minimally invasive surgery such as video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS), the use rate of carina-type endobronchial blockers has increased significantly, driving the growth of market demand. Carina-type endobronchial blockers are mainly used for thoracic surgery, lung isolation during single-lung ventilation, or treatment that requires differential lung ventilation. It completely or partially closes the airway through inflation to achieve precise lung isolation and ventilation control. Carina-type endobronchial blockers play an important role in lung cancer surgery, lung disease treatment, and lung function testing. In summary, the carina-type endobronchial blocker market has broad development prospects and huge market potential. With the continuous advancement of medical technology and the increase in clinical application demand, the market will continue to maintain a steady growth trend.

This report delivers a comprehensive overview of the global Carina Endobronchial Blocker market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Carina Endobronchial Blocker. The Carina Endobronchial Blocker market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Carina Endobronchial Blocker market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Carina Endobronchial Blocker manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Carina Endobronchial Blocker Market Report

Report Metric	Details
Report Name	Carina Endobronchial Blocker Market
Segment by Type	Visualization Non-Visualization
by Application	Thoracic Surgery Treatment of Lung Diseases Pulmonary Function Test Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teleflex, Cook Medical, Truphatek International, Olympus Medical, Ambu, MoNi Medical Technology, AMK Medical, SUMI, Well Lead Medical, P3 Medical, Vygon, Merit Medical, Stryker, Broncus Medical, Boston Scientific, Orcl MEDICAL Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Carina Endobronchial Blocker manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Carina Endobronchial Blocker sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Carina Endobronchial Blocker Market report?

Ans: The main players in the Carina Endobronchial Blocker Market are Teleflex, Cook Medical, Truphatek International, Olympus Medical, Ambu, MoNi Medical Technology, AMK Medical, SUMI, Well Lead Medical, P3 Medical, Vygon, Merit Medical, Stryker, Broncus Medical, Boston Scientific, Orcl MEDICAL Company

What are the Application segmentation covered in the Carina Endobronchial Blocker Market report?

Ans: The Applications covered in the Carina Endobronchial Blocker Market report are Thoracic Surgery, Treatment of Lung Diseases, Pulmonary Function Test, Other

What are the Type segmentation covered in the Carina Endobronchial Blocker Market report?

Ans: The Types covered in the Carina Endobronchial Blocker Market report are Visualization, Non-Visualization

1 Carina Endobronchial Blocker Market Overview

1.1 Product Definition

1.2 Carina Endobronchial Blocker by Type

1.2.1 Global Carina Endobronchial Blocker Market Value by Type: 2025 vs 2032

1.2.2 Visualization

1.2.3 Non-Visualization

1.3 Carina Endobronchial Blocker by Application

1.3.1 Global Carina Endobronchial Blocker Market Value by Application: 2025 vs 2032

1.3.2 Thoracic Surgery

1.3.3 Treatment of Lung Diseases

1.3.4 Pulmonary Function Test

1.3.5 Other

1.4 Global Carina Endobronchial Blocker Market Size Estimates and Forecasts

1.4.1 Global Carina Endobronchial Blocker Revenue 2021–2032

1.4.2 Global Carina Endobronchial Blocker Sales 2021–2032

1.4.3 Global Carina Endobronchial Blocker Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Carina Endobronchial Blocker Market Competition by Manufacturers

2.1 Global Carina Endobronchial Blocker Sales Market Share by Manufacturers (2021–2026)

2.2 Global Carina Endobronchial Blocker Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Carina Endobronchial Blocker Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Carina Endobronchial Blocker, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Carina Endobronchial Blocker, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Carina Endobronchial Blocker, Product Types and Applications

2.7 Global Key Manufacturers of Carina Endobronchial Blocker, Date of Entry into the Industry

2.8 Global Carina Endobronchial Blocker Market Competitive Situation and Trends

2.8.1 Global Carina Endobronchial Blocker Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Carina Endobronchial Blocker Players Market Share by Revenue

2.8.3 Global Carina Endobronchial Blocker Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Carina Endobronchial Blocker Market Scenario by Region

3.1 Global Carina Endobronchial Blocker Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Carina Endobronchial Blocker Sales by Region: 2021–2032

3.2.1 Global Carina Endobronchial Blocker Sales by Region: 2021–2026

3.2.2 Global Carina Endobronchial Blocker Sales by Region: 2027–2032

3.3 Global Carina Endobronchial Blocker Revenue by Region: 2021–2032

3.3.1 Global Carina Endobronchial Blocker Revenue by Region: 2021–2026

3.3.2 Global Carina Endobronchial Blocker Revenue by Region: 2027–2032

3.4 North America Carina Endobronchial Blocker Market Facts & Figures by Country

3.4.1 North America Carina Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Carina Endobronchial Blocker Sales by Country (2021–2032)

3.4.3 North America Carina Endobronchial Blocker Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Carina Endobronchial Blocker Market Facts & Figures by Country

3.5.1 Europe Carina Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Carina Endobronchial Blocker Sales by Country (2021–2032)

3.5.3 Europe Carina Endobronchial Blocker Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Carina Endobronchial Blocker Market Facts & Figures by Region

3.6.1 Asia Pacific Carina Endobronchial Blocker Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Carina Endobronchial Blocker Sales by Region (2021–2032)

3.6.3 Asia Pacific Carina Endobronchial Blocker Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Carina Endobronchial Blocker Market Facts & Figures by Country

3.7.1 Latin America Carina Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Carina Endobronchial Blocker Sales by Country (2021–2032)

3.7.3 Latin America Carina Endobronchial Blocker Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Carina Endobronchial Blocker Market Facts & Figures by Country

3.8.1 Middle East and Africa Carina Endobronchial Blocker Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Carina Endobronchial Blocker Sales by Country (2021–2032)

3.8.3 Middle East and Africa Carina Endobronchial Blocker Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Carina Endobronchial Blocker Sales by Type (2021–2032)

4.1.1 Global Carina Endobronchial Blocker Sales by Type (2021–2026)

4.1.2 Global Carina Endobronchial Blocker Sales by Type (2027–2032)

4.1.3 Global Carina Endobronchial Blocker Sales Market Share by Type (2021–2032)

4.2 Global Carina Endobronchial Blocker Revenue by Type (2021–2032)

4.2.1 Global Carina Endobronchial Blocker Revenue by Type (2021–2026)

4.2.2 Global Carina Endobronchial Blocker Revenue by Type (2027–2032)

4.2.3 Global Carina Endobronchial Blocker Revenue Market Share by Type (2021–2032)

4.3 Global Carina Endobronchial Blocker Price by Type (2021–2032)

5 Segment by Application

5.1 Global Carina Endobronchial Blocker Sales by Application (2021–2032)

5.1.1 Global Carina Endobronchial Blocker Sales by Application (2021–2026)

5.1.2 Global Carina Endobronchial Blocker Sales by Application (2027–2032)

5.1.3 Global Carina Endobronchial Blocker Sales Market Share by Application (2021–2032)

5.2 Global Carina Endobronchial Blocker Revenue by Application (2021–2032)

5.2.1 Global Carina Endobronchial Blocker Revenue by Application (2021–2026)

5.2.2 Global Carina Endobronchial Blocker Revenue by Application (2027–2032)

5.2.3 Global Carina Endobronchial Blocker Revenue Market Share by Application (2021–2032)

5.3 Global Carina Endobronchial Blocker Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Teleflex

6.1.1 Teleflex Company Information

6.1.2 Teleflex Description and Business Overview

6.1.3 Teleflex Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Teleflex Carina Endobronchial Blocker Product Portfolio

6.1.5 Teleflex Recent Developments/Updates

6.2 Cook Medical

6.2.1 Cook Medical Company Information

6.2.2 Cook Medical Description and Business Overview

6.2.3 Cook Medical Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Cook Medical Carina Endobronchial Blocker Product Portfolio

6.2.5 Cook Medical Recent Developments/Updates

6.3 Truphatek International

6.3.1 Truphatek International Company Information

6.3.2 Truphatek International Description and Business Overview

6.3.3 Truphatek International Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Truphatek International Carina Endobronchial Blocker Product Portfolio

6.3.5 Truphatek International Recent Developments/Updates

6.4 Olympus Medical

6.4.1 Olympus Medical Company Information

6.4.2 Olympus Medical Description and Business Overview

6.4.3 Olympus Medical Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Olympus Medical Carina Endobronchial Blocker Product Portfolio

6.4.5 Olympus Medical Recent Developments/Updates

6.5 Ambu

6.5.1 Ambu Company Information

6.5.2 Ambu Description and Business Overview

6.5.3 Ambu Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Ambu Carina Endobronchial Blocker Product Portfolio

6.5.5 Ambu Recent Developments/Updates

6.6 MoNi Medical Technology

6.6.1 MoNi Medical Technology Company Information

6.6.2 MoNi Medical Technology Description and Business Overview

6.6.3 MoNi Medical Technology Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 MoNi Medical Technology Carina Endobronchial Blocker Product Portfolio

6.6.5 MoNi Medical Technology Recent Developments/Updates

6.7 AMK Medical

6.7.1 AMK Medical Company Information

6.7.2 AMK Medical Description and Business Overview

6.7.3 AMK Medical Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 AMK Medical Carina Endobronchial Blocker Product Portfolio

6.7.5 AMK Medical Recent Developments/Updates

6.8 SUMI

6.8.1 SUMI Company Information

6.8.2 SUMI Description and Business Overview

6.8.3 SUMI Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 SUMI Carina Endobronchial Blocker Product Portfolio

6.8.5 SUMI Recent Developments/Updates

6.9 Well Lead Medical

6.9.1 Well Lead Medical Company Information

6.9.2 Well Lead Medical Description and Business Overview

6.9.3 Well Lead Medical Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Well Lead Medical Carina Endobronchial Blocker Product Portfolio

6.9.5 Well Lead Medical Recent Developments/Updates

6.10 P3 Medical

6.10.1 P3 Medical Company Information

6.10.2 P3 Medical Description and Business Overview

6.10.3 P3 Medical Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 P3 Medical Carina Endobronchial Blocker Product Portfolio

6.10.5 P3 Medical Recent Developments/Updates

6.11 Vygon

6.11.1 Vygon Company Information

6.11.2 Vygon Description and Business Overview

6.11.3 Vygon Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Vygon Carina Endobronchial Blocker Product Portfolio

6.11.5 Vygon Recent Developments/Updates

6.12 Merit Medical

6.12.1 Merit Medical Company Information

6.12.2 Merit Medical Description and Business Overview

6.12.3 Merit Medical Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Merit Medical Carina Endobronchial Blocker Product Portfolio

6.12.5 Merit Medical Recent Developments/Updates

6.13 Stryker

6.13.1 Stryker Company Information

6.13.2 Stryker Description and Business Overview

6.13.3 Stryker Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Stryker Carina Endobronchial Blocker Product Portfolio

6.13.5 Stryker Recent Developments/Updates

6.14 Broncus Medical

6.14.1 Broncus Medical Company Information

6.14.2 Broncus Medical Description and Business Overview

6.14.3 Broncus Medical Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Broncus Medical Carina Endobronchial Blocker Product Portfolio

6.14.5 Broncus Medical Recent Developments/Updates

6.15 Boston Scientific

6.15.1 Boston Scientific Company Information

6.15.2 Boston Scientific Description and Business Overview

6.15.3 Boston Scientific Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Boston Scientific Carina Endobronchial Blocker Product Portfolio

6.15.5 Boston Scientific Recent Developments/Updates

6.16 Orcl MEDICAL Company

6.16.1 Orcl MEDICAL Company Company Information

6.16.2 Orcl MEDICAL Company Description and Business Overview

6.16.3 Orcl MEDICAL Company Carina Endobronchial Blocker Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Orcl MEDICAL Company Carina Endobronchial Blocker Product Portfolio

6.16.5 Orcl MEDICAL Company Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Carina Endobronchial Blocker Industry Chain Analysis

7.2 Carina Endobronchial Blocker Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Carina Endobronchial Blocker Production Mode & Process Analysis

7.4 Carina Endobronchial Blocker Sales and Marketing

7.4.1 Carina Endobronchial Blocker Sales Channels

7.4.2 Carina Endobronchial Blocker Distributors

7.5 Carina Endobronchial Blocker Customer Analysis

8 Carina Endobronchial Blocker Market Dynamics

8.1 Carina Endobronchial Blocker Industry Trends

8.2 Carina Endobronchial Blocker Market Drivers

8.3 Carina Endobronchial Blocker Market Challenges

8.4 Carina Endobronchial Blocker Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Teleflex

Cook Medical

Truphatek International

MoNi Medical Technology

Orcl MEDICAL Company

List of Tables

Table 1. Global Carina Endobronchial Blocker Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Carina Endobronchial Blocker Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Carina Endobronchial Blocker Market Competitive Situation by Manufacturers in 2025

Table 4. Global Carina Endobronchial Blocker Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Carina Endobronchial Blocker Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Carina Endobronchial Blocker Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Carina Endobronchial Blocker Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Carina Endobronchial Blocker Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Carina Endobronchial Blocker, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Carina Endobronchial Blocker, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Carina Endobronchial Blocker, Product Types and Applications

Table 12. Global Key Manufacturers of Carina Endobronchial Blocker, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Carina Endobronchial Blocker Companies by Tier (Tier 1, Tier 2, Tier 3), based on Carina Endobronchial Blocker Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Carina Endobronchial Blocker Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Carina Endobronchial Blocker Sales by Region (K Units), 2021–2026

Table 18. Global Carina Endobronchial Blocker Sales Market Share by Region (2021–2026)

Table 19. Global Carina Endobronchial Blocker Sales by Region (K Units), 2027–2032

Table 20. Global Carina Endobronchial Blocker Sales Market Share by Region (2027–2032)

Table 21. Global Carina Endobronchial Blocker Revenue by Region (US$ Million), 2021–2026

Table 22. Global Carina Endobronchial Blocker Revenue Market Share by Region (2021–2026)

Table 23. Global Carina Endobronchial Blocker Revenue by Region (US$ Million), 2027–2032

Table 24. Global Carina Endobronchial Blocker Revenue Market Share by Region (2027–2032)

Table 25. North America Carina Endobronchial Blocker Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Carina Endobronchial Blocker Sales by Country (K Units), 2021–2026

Table 27. North America Carina Endobronchial Blocker Sales by Country (K Units), 2027–2032

Table 28. North America Carina Endobronchial Blocker Revenue by Country (US$ Million), 2021–2026

Table 29. North America Carina Endobronchial Blocker Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Carina Endobronchial Blocker Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Carina Endobronchial Blocker Sales by Country (K Units), 2021–2026

Table 32. Europe Carina Endobronchial Blocker Sales by Country (K Units), 2027–2032

Table 33. Europe Carina Endobronchial Blocker Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Carina Endobronchial Blocker Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Carina Endobronchial Blocker Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Carina Endobronchial Blocker Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Carina Endobronchial Blocker Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Carina Endobronchial Blocker Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Carina Endobronchial Blocker Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Carina Endobronchial Blocker Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Carina Endobronchial Blocker Sales by Country (K Units), 2021–2026

Table 42. Latin America Carina Endobronchial Blocker Sales by Country (K Units), 2027–2032

Table 43. Latin America Carina Endobronchial Blocker Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Carina Endobronchial Blocker Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Carina Endobronchial Blocker Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Carina Endobronchial Blocker Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Carina Endobronchial Blocker Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Carina Endobronchial Blocker Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Carina Endobronchial Blocker Revenue by Country (US$ Million), 2027–2032

Table 50. Global Carina Endobronchial Blocker Sales (K Units) by Type (2021–2026)

Table 51. Global Carina Endobronchial Blocker Sales (K Units) by Type (2027–2032)

Table 52. Global Carina Endobronchial Blocker Sales Market Share by Type (2021–2026)

Table 53. Global Carina Endobronchial Blocker Sales Market Share by Type (2027–2032)

Table 54. Global Carina Endobronchial Blocker Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Carina Endobronchial Blocker Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Carina Endobronchial Blocker Revenue Market Share by Type (2021–2026)

Table 57. Global Carina Endobronchial Blocker Revenue Market Share by Type (2027–2032)

Table 58. Global Carina Endobronchial Blocker Price (US$/Unit) by Type (2021–2026)

Table 59. Global Carina Endobronchial Blocker Price (US$/Unit) by Type (2027–2032)

Table 60. Global Carina Endobronchial Blocker Sales (K Units) by Application (2021–2026)

Table 61. Global Carina Endobronchial Blocker Sales (K Units) by Application (2027–2032)

Table 62. Global Carina Endobronchial Blocker Sales Market Share by Application (2021–2026)

Table 63. Global Carina Endobronchial Blocker Sales Market Share by Application (2027–2032)

Table 64. Global Carina Endobronchial Blocker Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Carina Endobronchial Blocker Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Carina Endobronchial Blocker Revenue Market Share by Application (2021–2026)

Table 67. Global Carina Endobronchial Blocker Revenue Market Share by Application (2027–2032)

Table 68. Global Carina Endobronchial Blocker Price (US$/Unit) by Application (2021–2026)

Table 69. Global Carina Endobronchial Blocker Price (US$/Unit) by Application (2027–2032)

Table 70. Teleflex Company Information

Table 71. Teleflex Description and Business Overview

Table 72. Teleflex Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Teleflex Carina Endobronchial Blocker Product

Table 74. Teleflex Recent Developments/Updates

Table 75. Cook Medical Company Information

Table 76. Cook Medical Description and Business Overview

Table 77. Cook Medical Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Cook Medical Carina Endobronchial Blocker Product

Table 79. Cook Medical Recent Developments/Updates

Table 80. Truphatek International Company Information

Table 81. Truphatek International Description and Business Overview

Table 82. Truphatek International Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Truphatek International Carina Endobronchial Blocker Product

Table 84. Truphatek International Recent Developments/Updates

Table 85. Olympus Medical Company Information

Table 86. Olympus Medical Description and Business Overview

Table 87. Olympus Medical Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Olympus Medical Carina Endobronchial Blocker Product

Table 89. Olympus Medical Recent Developments/Updates

Table 90. Ambu Company Information

Table 91. Ambu Description and Business Overview

Table 92. Ambu Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Ambu Carina Endobronchial Blocker Product

Table 94. Ambu Recent Developments/Updates

Table 95. MoNi Medical Technology Company Information

Table 96. MoNi Medical Technology Description and Business Overview

Table 97. MoNi Medical Technology Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. MoNi Medical Technology Carina Endobronchial Blocker Product

Table 99. MoNi Medical Technology Recent Developments/Updates

Table 100. AMK Medical Company Information

Table 101. AMK Medical Description and Business Overview

Table 102. AMK Medical Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. AMK Medical Carina Endobronchial Blocker Product

Table 104. AMK Medical Recent Developments/Updates

Table 105. SUMI Company Information

Table 106. SUMI Description and Business Overview

Table 107. SUMI Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. SUMI Carina Endobronchial Blocker Product

Table 109. SUMI Recent Developments/Updates

Table 110. Well Lead Medical Company Information

Table 111. Well Lead Medical Description and Business Overview

Table 112. Well Lead Medical Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Well Lead Medical Carina Endobronchial Blocker Product

Table 114. Well Lead Medical Recent Developments/Updates

Table 115. P3 Medical Company Information

Table 116. P3 Medical Description and Business Overview

Table 117. P3 Medical Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 118. P3 Medical Carina Endobronchial Blocker Product

Table 119. P3 Medical Recent Developments/Updates

Table 120. Vygon Company Information

Table 121. Vygon Description and Business Overview

Table 122. Vygon Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 123. Vygon Carina Endobronchial Blocker Product

Table 124. Vygon Recent Developments/Updates

Table 125. Merit Medical Company Information

Table 126. Merit Medical Description and Business Overview

Table 127. Merit Medical Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 128. Merit Medical Carina Endobronchial Blocker Product

Table 129. Merit Medical Recent Developments/Updates

Table 130. Stryker Company Information

Table 131. Stryker Description and Business Overview

Table 132. Stryker Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 133. Stryker Carina Endobronchial Blocker Product

Table 134. Stryker Recent Developments/Updates

Table 135. Broncus Medical Company Information

Table 136. Broncus Medical Description and Business Overview

Table 137. Broncus Medical Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 138. Broncus Medical Carina Endobronchial Blocker Product

Table 139. Broncus Medical Recent Developments/Updates

Table 140. Boston Scientific Company Information

Table 141. Boston Scientific Description and Business Overview

Table 142. Boston Scientific Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 143. Boston Scientific Carina Endobronchial Blocker Product

Table 144. Boston Scientific Recent Developments/Updates

Table 145. Orcl MEDICAL Company Company Information

Table 146. Orcl MEDICAL Company Description and Business Overview

Table 147. Orcl MEDICAL Company Carina Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 148. Orcl MEDICAL Company Carina Endobronchial Blocker Product

Table 149. Orcl MEDICAL Company Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Carina Endobronchial Blocker Distributors List

Table 153. Carina Endobronchial Blocker Customers List

Table 154. Carina Endobronchial Blocker Market Trends

Table 155. Carina Endobronchial Blocker Market Drivers

Table 156. Carina Endobronchial Blocker Market Challenges

Table 157. Carina Endobronchial Blocker Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Carina Endobronchial Blocker

Figure 2. Global Carina Endobronchial Blocker Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Carina Endobronchial Blocker Market Share by Type: 2025 & 2032

Figure 4. Visualization Product Picture

Figure 5. Non-Visualization Product Picture

Figure 6. Global Carina Endobronchial Blocker Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Carina Endobronchial Blocker Market Share by Application: 2025 & 2032

Figure 8. Thoracic Surgery

Figure 9. Treatment of Lung Diseases

Figure 10. Pulmonary Function Test

Figure 11. Other

Figure 12. Global Carina Endobronchial Blocker Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Carina Endobronchial Blocker Market Size (US$ Million), 2021–2032

Figure 14. Global Carina Endobronchial Blocker Sales (K Units), 2021–2032

Figure 15. Global Carina Endobronchial Blocker Average Price (US$/Unit), 2021–2032

Figure 16. Carina Endobronchial Blocker Report Years Considered

Figure 17. Carina Endobronchial Blocker Sales Share by Manufacturers in 2025

Figure 18. Global Carina Endobronchial Blocker Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global Carina Endobronchial Blocker Players: Market Share by Revenue in Carina Endobronchial Blocker in 2025

Figure 20. Carina Endobronchial Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global Carina Endobronchial Blocker Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America Carina Endobronchial Blocker Sales Market Share by Country (2021–2032)

Figure 23. North America Carina Endobronchial Blocker Revenue Market Share by Country (2021–2032)

Figure 24. United States Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe Carina Endobronchial Blocker Sales Market Share by Country (2021–2032)

Figure 27. Europe Carina Endobronchial Blocker Revenue Market Share by Country (2021–2032)

Figure 28. Germany Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific Carina Endobronchial Blocker Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific Carina Endobronchial Blocker Revenue Market Share by Region (2021–2032)

Figure 35. China Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Southeast Asia Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America Carina Endobronchial Blocker Sales Market Share by Country (2021–2032)

Figure 43. Latin America Carina Endobronchial Blocker Revenue Market Share by Country (2021–2032)

Figure 44. Mexico Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Colombia Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa Carina Endobronchial Blocker Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa Carina Endobronchial Blocker Revenue Market Share by Country (2021–2032)

Figure 50. Turkey Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE Carina Endobronchial Blocker Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of Carina Endobronchial Blocker by Type (2021–2032)

Figure 54. Global Revenue Market Share of Carina Endobronchial Blocker by Type (2021–2032)

Figure 55. Global Carina Endobronchial Blocker Price (US$/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of Carina Endobronchial Blocker by Application (2021–2032)

Figure 57. Global Revenue Market Share of Carina Endobronchial Blocker by Application (2021–2032)

Figure 58. Global Carina Endobronchial Blocker Price (US$/Unit) by Application (2021–2032)

Figure 59. Carina Endobronchial Blocker Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions